Dr Alfred A Sidhom, MD | |
1211 W La Palma Ave Ste 502, Anaheim, CA 92801-2812 | |
(714) 776-7090 | |
(714) 776-5632 |
Full Name | Dr Alfred A Sidhom |
---|---|
Gender | Male |
Speciality | Urology |
Location | 1211 W La Palma Ave Ste 502, Anaheim, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114923265 | NPI | - | NPPES |
00A355260M92 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | A35526 (California) | Primary |
Entity Name | Alfred A Sidhom M D Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154441343 PECOS PAC ID: 9335053420 Enrollment ID: O20031113000398 |
News Archive
Following the 2010 FDA directive, pharmaceutical manufacturer Glaxo-SmithKline announced this Monday that they have modified the label for diabetes drug rosiglitazone (Avandia). The new label restricts its use to patients already taking it or to those who have failed other antiglycemic drugs.
Aspyra, Inc. today announced plans to demonstrate the latest release of AccessNET, the Company's PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.
Merck & Co. today announced that its shareholders voted overwhelmingly to approve the proposed merger with Schering-Plough. The preliminary tabulation indicates that more than 99% of the company's outstanding shares voted in favor of the transaction. Merck today held its special shareholder meeting in Bridgewater, New Jersey to vote on the proposed merger.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai.
› Verified 5 days ago
Entity Name | Uci Department Of Urology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255398533 PECOS PAC ID: 6901799238 Enrollment ID: O20040202001148 |
News Archive
Following the 2010 FDA directive, pharmaceutical manufacturer Glaxo-SmithKline announced this Monday that they have modified the label for diabetes drug rosiglitazone (Avandia). The new label restricts its use to patients already taking it or to those who have failed other antiglycemic drugs.
Aspyra, Inc. today announced plans to demonstrate the latest release of AccessNET, the Company's PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.
Merck & Co. today announced that its shareholders voted overwhelmingly to approve the proposed merger with Schering-Plough. The preliminary tabulation indicates that more than 99% of the company's outstanding shares voted in favor of the transaction. Merck today held its special shareholder meeting in Bridgewater, New Jersey to vote on the proposed merger.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alfred A Sidhom, MD 1211 W La Palma Ave, Ste 502, Anaheim, CA 92801-2812 Ph: (714) 776-7090 | Dr Alfred A Sidhom, MD 1211 W La Palma Ave Ste 502, Anaheim, CA 92801-2812 Ph: (714) 776-7090 |
News Archive
Following the 2010 FDA directive, pharmaceutical manufacturer Glaxo-SmithKline announced this Monday that they have modified the label for diabetes drug rosiglitazone (Avandia). The new label restricts its use to patients already taking it or to those who have failed other antiglycemic drugs.
Aspyra, Inc. today announced plans to demonstrate the latest release of AccessNET, the Company's PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.
Merck & Co. today announced that its shareholders voted overwhelmingly to approve the proposed merger with Schering-Plough. The preliminary tabulation indicates that more than 99% of the company's outstanding shares voted in favor of the transaction. Merck today held its special shareholder meeting in Bridgewater, New Jersey to vote on the proposed merger.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai.
› Verified 5 days ago
Khoa Binh Tran, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Dr. Manilal B Mehta, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1211 W La Palma Ave, Ste 502, Anaheim, CA 92801 Phone: 714-776-7090 Fax: 714-776-5632 | |
Yenning Chuang, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Frank W. Newman, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Mr. Richard E Wineland, Urology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, 307, Anaheim, CA 92801 Phone: 714-776-6456 Fax: 714-776-6924 | |
Dr. George Abdelsayed, Urology Medicare: Accepting Medicare Assignments Practice Location: 3430 E La Palma Ave, Medical Office Building 2, Anaheim, CA 92806 Phone: 310-920-3544 |